Weekly Investment Analysts’ Ratings Updates for AstraZeneca (AZN)

Several brokerages have updated their recommendations and price targets on shares of AstraZeneca (LON: AZN) in the last few weeks:

• 8/4/2026 – AstraZeneca had its “sector perform” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a £115 price target on the stock.
• 8/3/2026 – AstraZeneca had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a £175 price target on the stock.
• 7/28/2026 – AstraZeneca had its “sell” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a £115 price target on the stock.
• 7/28/2026 – AstraZeneca had its price target raised by Citigroup Inc. from £175 to £178. They now have a “buy” rating on the stock.
• 7/28/2026 – AstraZeneca had its “buy” rating reaffirmed by Berenberg Bank. They now have a £160 price target on the stock.
• 7/10/2026 – AstraZeneca was downgraded by Citigroup Inc. to “buy”.
• 6/26/2026 – AstraZeneca had its “sell” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a £115 price target on the stock.
• 6/26/2026 – AstraZeneca had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a £180 price target on the stock.
• 6/11/2026 – AstraZeneca had its “sell” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a £115 price target on the stock.
• 6/9/2026 – AstraZeneca had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a £180 price target on the stock.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.